Management of Upper Gastrointestinal Bleeding with Proton Pump Inhibitors

Recommended PPI Regimen

The American College of Physicians recommends a standard high-dose regimen for acute upper GI bleeding, consisting of an 80 mg IV bolus followed by continuous infusion at 8 mg/hour for 72 hours after successful endoscopic therapy, which significantly reduces rebleeding rates, need for surgery, and mortality compared to H2-receptor antagonists or placebo 3, 4, 5
This high-dose PPI regimen has Grade A evidence with 100% consensus from expert panels, indicating a strong recommendation for its use in upper GI bleeding 2, 4

The American Gastroenterological Association states that the benefits of proton pump inhibitors in upper GI bleeding are likely a class effect, meaning that different PPIs are considered equally effective 1
Both intravenous omeprazole and pantoprazole (80 mg bolus followed by 8 mg/h for 72 hours) are considered effective after endoscopic therapy, with similar efficacy demonstrated for pantoprazole and esomeprazole 2

For patients with upper GI bleeding requiring IV PPI therapy, either pantoprazole or esomeprazole can be used effectively, with the choice between agents depending on local hospital formulary availability, cost considerations, and physician familiarity with the medication 2, 3, 1, 5
After 72 hours of IV therapy, patients should be transitioned to oral PPI therapy, as recommended by the American College of Gastroenterology 4

PPI therapy is an adjunct to, not a replacement for, endoscopic therapy in upper GI bleeding, and testing for and treating H. pylori infection is recommended for patients with upper GI bleeding, as eradication reduces the risk of recurrent bleeding 4, 1
For patients requiring NSAIDs, a PPI with a cyclooxygenase-2 inhibitor is preferred to reduce rebleeding, as recommended by the American Heart Association 5